Literature DB >> 16106061

Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Anne H Cross1, Jennifer L Stark.   

Abstract

Abnormal immunoglobulin synthesis within the central nervous system is a common finding in patients with multiple sclerosis (MS) that is often used for diagnosis. However, it is not clear whether antibodies, or the B-cells and plasma cells that make them, are critical to the pathogenesis of MS. Here we review the descriptive data that suggest a role for antibody in the pathogenesis of MS. The results of B-cell and antibody depletion studies in the animal model for MS, experimental autoimmune encephalomyelitis, are summarized, as well as early data using a chimeric monoclonal antibody to deplete B-cells in patients with MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106061     DOI: 10.1385/IR:32:1-3:085

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  88 in total

1.  Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement.

Authors:  J N Whitaker; B E Sparks; D P Walker; R Goodin; E N Benveniste
Journal:  J Neuroimmunol       Date:  1989-04       Impact factor: 3.478

2.  Specific plasma cell accumulation in antigen-induced chronic inflammation in the guinea pig peritoneal cavity.

Authors:  A C van Dinther-Janssen; L Hofland; R J Scheper
Journal:  Int Arch Allergy Appl Immunol       Date:  1986

3.  The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages.

Authors:  A Van der Goes; M Kortekaas; K Hoekstra; C D Dijkstra; S Amor
Journal:  J Neuroimmunol       Date:  1999-11-01       Impact factor: 3.478

4.  Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig.

Authors:  T Tabira; M Endoh
Journal:  J Neurol Sci       Date:  1985-02       Impact factor: 3.181

5.  Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis.

Authors:  S Cepok; M Jacobsen; S Schock; B Omer; S Jaekel; I Böddeker; W H Oertel; N Sommer; B Hemmer
Journal:  Brain       Date:  2001-11       Impact factor: 13.501

6.  Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis.

Authors:  F Lolli; G M Liuzzi; M Vergelli; L Massacesi; C Ballerini; L Amaducci; P Riccio
Journal:  J Neuroimmunol       Date:  1993-04       Impact factor: 3.478

7.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

Authors:  P Hjelmström; A E Juedes; J Fjell; N H Ruddle
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

9.  Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis.

Authors:  D O Willenborg; S J Prowse
Journal:  J Neuroimmunol       Date:  1983-10       Impact factor: 3.478

10.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.

Authors:  David Luckey; Dikshya Bastakoty; Ashutosh K Mangalam
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

Review 2.  Development of anti-CD20 therapy for multiple sclerosis.

Authors:  Beatrix Bartok; Gregg J Silverman
Journal:  Exp Cell Res       Date:  2011-04-12       Impact factor: 3.905

Review 3.  The potential role of B cell-targeted therapies in multiple sclerosis.

Authors:  Aaron Boster; Daniel P Ankeny; Michael K Racke
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

4.  Peripheral nerve protein expression and carbonyl content in N,N-diethlydithiocarbamate myelinopathy.

Authors:  Olga M Viquez; Holly L Valentine; David B Friedman; Sandra J Olson; William M Valentine
Journal:  Chem Res Toxicol       Date:  2007-02-27       Impact factor: 3.739

5.  B cells as a target of immune modulation.

Authors:  Kathleen Hawker
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.